United Kingdom· GB-APID-786611000001108
Myocrisin 50mg/0.5ml solution for injection ampoules
A sodium aurothiomalate product containing sodium aurothiomalate, registered in United Kingdom by Sanofi. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sodium aurothiomalate is registered in 2 of 19 countries.
Countries holding a registration under ATC M01CB01 (sodium aurothiomalate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Sodium aurothiomalate · ATC M01CB01
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sodium aurothiomalate
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- M01CB01
- ATC class
- Sodium aurothiomalate
- Defined daily dose
- 2.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000283651659
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for sodium aurothiomalate.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium aurothiomalate · interactions on record
85 records
- 16 severe
- 69 moderate
Most severe, free to view
- CladribineL01BB04severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium aurothiomalate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17c9cda2-b336-48c5-924f-82e9c62b7ba6 GET /v1/drugs/17c9cda2-b336-48c5-924f-82e9c62b7ba6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "786611000001108",
"desc": "Myocrisin 50mg/0.5ml solution for injection ampoules (Sanofi)",
"form": "Solution for injection",
"vpid": "35924711000001105",
"source": "dmd",
"vtm_id": "777546008",
"strength": "100 mg",
"substance": "Sodium aurothiomalate",
"ingredient": "Sodium aurothiomalate",
"supplier_code": "9190711000001101"
}See everything about sodium aurothiomalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.